巩膜
药物输送
医学
眼球后段
眼科
药品
输送系统
药理学
材料科学
纳米技术
作者
Dayle H. Geroski,Henry F. Edelhauser
出处
期刊:AAPS advances in the pharmaceutical sciences series
日期:2011-01-01
卷期号:: 159-171
被引量:4
标识
DOI:10.1007/978-1-4419-9920-7_7
摘要
The treatment of diseases of the posterior segment of the eye remains limited by the ability to deliver effective doses of drugs to target tissues in the posterior eye. Topical delivery as drops and systemic delivery require large doses and remain limited in delivering effective doses to the back of the eye. Intravitreal injection and implantation of intravitreal sustained-release delivery devices are effective but invasive, and both modes of delivery share potential risks of retinal detachment, endophtalmitis, hemorrhage, and cataract. Numerous studies have demonstrated that drugs and solutes can diffuse across the sclera in vitro and in situ when delivered by a periocular approach. Transscleral delivery could provide an effective alternative approach for delivering therapeutic agents to the posterior tissues of the eye.
科研通智能强力驱动
Strongly Powered by AbleSci AI